-The Hindu Business Line To have one member from December 11; India has 3 pending appeals before it Geneva: The US has finally spiked the World Trade Organization’s Appellate Body, the highest adjudicating body for resolving global trade disputes. It shall remain dysfunctional after December 10, when it will be reduced to one member, said trade envoys. As a parting shot, the US on Tuesday blocked an initiative under Rule 15 of the...
More »SEARCH RESULT
Total Matching Records found : 7
India to appeal against WTO solar ruling in next few days
-PTI London: The February ruling came in the wake of a U.S. complaint before the global trade body alleging discrimination against American firms. India will appeal against WTO panel’s ruling that the country’s power purchase agreements with solar firms were “inconsistent” with international norms, in the next few days. The February ruling came in the wake of a U.S. complaint before the global trade body alleging discrimination against American firms. “Next few days,” said...
More »WTO panel rules against India in solar dispute -D Ravi Kanth, Asit Ranjan Mishra & Utpal Bhaskar
-Livemint.com Govt likely to appeal ruling that requires it to offer level playing field to domestic and foreign manufacturers Geneva/New Delhi: A World Trade Organization (WTO) panel has ruled against India in a dispute raised by the US over the country’s solar power programme, requiring the government to offer a level playing field to both foreign and domestic manufacturers of solar panels. India is likely to appeal against the dispute settlement panel’s ruling,...
More »India loses poultry case against U.S. at WTO
-PTI WTO ruled that the Indian ban on import of poultry meat, eggs and live pigs from the U.S. was "inconsistent" with the international norms. Geneva/Washington: India has lost a case at the World Trade Organisation (WTO) as the body on Thursday ruled that the Indian ban on import of poultry meat, eggs and live pigs from the U.S. was “inconsistent” with the international norms. India will have 12-18 months to implement this...
More »Landmark verdict -V Venkatesan
-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »
